Trials / Completed
CompletedNCT01133548
Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males
A Multiple Dose Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of 5 g Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the pharmacokinetics and comparative bioavailability of Testosterone absorption in 36 Hypogonadal males after administration of 5 g Testosterone Gel 1.62% to the upper arms/shoulders using an application site rotation or a combination of application sites.
Detailed description
To evaluate the pharmacokinetics and comparative bioavailability of Testosterone absorption in 36 Hypogonadal males after administration of 5 g Testosterone Gel 1.62% to the upper arms/shoulders using an application site rotation or a combination of application sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone Gel 1.62% | 5 grams administered using an application Site Rotation |
| DRUG | Testosterone Gel 1.62% | 5 grams administered using an a combination of Application sites |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-05-31
- Last updated
- 2017-12-07
Source: ClinicalTrials.gov record NCT01133548. Inclusion in this directory is not an endorsement.